These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3113779)

  • 21. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.
    Gelato MC; Oldfield E; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1990 Sep; 71(3):585-90. PubMed ID: 2118536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of continuous somatostatin and growth hormone-releasing hormone (GHRH) infusions on the subsequent growth hormone (GH) response to GHRH. Evidence for somatotroph desensitization independent of GH pool depletion.
    Rittmaster RS; Loriaux DL; Merriam GR
    Neuroendocrinology; 1987 Feb; 45(2):118-22. PubMed ID: 2883595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of hyperthyroidism on growth hormone secretion.
    Valcavi R; Dieguez C; Zini M; Muruais C; Casanueva F; Portioli I
    Clin Endocrinol (Oxf); 1993 May; 38(5):515-22. PubMed ID: 8330446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pulsatile GH secretion in acromegaly: hypothalamic or pituitary origin?
    Riedel M; Günther T; von zur Mühlen A; Brabant G
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):233-9. PubMed ID: 1358484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of cholinergic tone in modulating the growth hormone response to growth hormone-releasing hormone in normal man.
    Giustina A; Bossoni S; Bodini C; Doga M; Girelli A; Buffoli MG; Schettino M; Wehrenberg WB
    Metabolism; 1991 May; 40(5):519-23. PubMed ID: 2023538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
    Jaffe CA; Turgeon DK; Friberg RD; Watkins PB; Barkan AL
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.
    Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Awouters M; Verbruggen W; Schetz M; Verwaest C; Lauwers P; Bouillon R; Bowers CY
    J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galanin infusion partially restores the blunted growth hormone responses to repeated growth hormone releasing hormone stimuli in normal adults.
    Sartorio A; Spada A; Conti A; Grugni G; Morabito F; Faglia G
    J Endocrinol Invest; 1993 Feb; 16(2):95-8. PubMed ID: 7681861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction of growth hormone releasing hormone and somatostatin in the generation of a GH pulse in man.
    Hindmarsh PC; Brain CE; Robinson IC; Matthews DR; Brook CG
    Clin Endocrinol (Oxf); 1991 Oct; 35(4):353-60. PubMed ID: 1684314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men.
    Jaffe CA; Ho PJ; Demott-Friberg R; Bowers CY; Barkan AL
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1641-7. PubMed ID: 7903313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents.
    Laron Z; Bowers CY; Hirsch D; Almonte AS; Pelz M; Keret R; Gil-Ad I
    Acta Endocrinol (Copenh); 1993 Nov; 129(5):424-6. PubMed ID: 8279223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
    Alba-Roth J; Müller OA; Schopohl J; von Werder K
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous refeeding blocks growth hormone (GH)-provoked rises in serum free fatty acids and blunting of somatotroph response to GH-releasing hormone in normal men.
    Rosenbaum M; Fong YM; Hesse DG; Tracey KJ; Hintz RL; Lowry SF; Gertner JM
    J Clin Endocrinol Metab; 1989 Aug; 69(2):310-6. PubMed ID: 2502553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Divergence between growth hormone responses to insulin-induced hypoglycaemia and growth hormone-releasing hormone in patients with non-functioning pituitary macroadenomas and hyperprolactinaemia.
    Beentjes JA; Tjeerdsma G; Sluiter WJ; Dullaart RP
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):391-8. PubMed ID: 8959076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does growth hormone releasing factor desensitize the somatotroph? Interpretation of responses of growth hormone during and after 10-hour infusion of GRF 1-29 amide in man.
    Davis JR; Sheppard MC; Shakespear RA; Lynch SS; Clayton RN
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):135-40. PubMed ID: 2871948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
    Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV
    Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute hyperglycemia and activation of the beta-adrenergic system exhibit synergistic inhibitory actions on growth hormone (GH) releasing hormone-induced GH release.
    Park C; Yang I; Woo J; Kim S; Kim J; Kim Y; Park S
    Eur J Endocrinol; 2003 Jun; 148(6):635-40. PubMed ID: 12773135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological levels of growth hormone fail to suppress growth hormone releasing hormone (1-29) NH2-stimulated growth hormone secretion in man.
    Brain C; Thakrar DN; Hindmarsh PC; Brook CG
    J Endocrinol Invest; 1993 Jan; 16(1):15-20. PubMed ID: 8445152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary.
    Casanueva FF; Villanueva L; Dieguez C; Diaz Y; Cabranes JA; Szoke B; Scanlon MF; Schally AV; Fernandez-Cruz A
    J Clin Endocrinol Metab; 1987 Oct; 65(4):634-42. PubMed ID: 2888782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.